Viewing Study NCT04847050


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-27 @ 4:23 AM
Study NCT ID: NCT04847050
Status: COMPLETED
Last Update Posted: 2024-08-27
First Post: 2021-04-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-04-28
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-25
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-25
Completion Date Type: ACTUAL
First Submit Date: 2021-04-14
First Submit QC Date: None
Study First Post Date: 2021-04-15
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-07-01
Results First Submit QC Date: None
Results First Post Date: 2024-08-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2024-08-27
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-08-05
Last Update Post Date: 2024-08-27
Last Update Post Date Type: ACTUAL